Chart Documentation by General Physicians of the Glaucoma Medications Taken by Their Patients - 18/08/11
, Parag Parekh, MD a, Elizabeth Johnson, MS b, Rhonda Miller, COA a
Inquiries to Henry D. Jampel, MD, Maumenee B-117, 600 N. Wolfe Street, Baltimore, MD 21287-9205; fax (410) 502-7493Résumé |
Purpose |
To estimate the frequency of documentation of glaucoma medications by primary care physicians.
Design |
Cross-sectional, observational study.
Methods |
The general medical records of 100 patients of one glaucoma specialist were reviewed. We recorded whether the mention of eyedrops appeared in the medical record.
Results |
The median number of glaucoma medications used was 2.5 (range 1 to 5). Fifty-five (55%, 95% confidence interval: 45%–65%) of the medical records of the primary physicians mentioned eyedrops. ⍺-Agonists were statistically less frequently documented (13%) in the general medical record than β-adrenergic blockers (47%) and prostaglandins (44%).
Conclusion |
Almost half of the charts of these primary physicians had no documentation of any eyedrop use by their patients with glaucoma. An important step in reducing drug-induced side effects and interactions with other medications would be better recognition by primary physicians of the ophthalmic drugs used by their patients.
Le texte complet de cet article est disponible en PDF.| Dr. Jampel is the recipient of a Physician Scientist Award from Research to Prevent Blindness. |
Vol 140 - N° 2
P. 344-345 - août 2005 Retour au numéro
Article précédent
- Accommodative Intraocular Lens Tilting
- Jorge Cazal, Cosme Lavin-Dapena, Jesus Marín, Carlos Vergés
- Testing Distance Stereoacuity With the Frisby-Davis 2 (FD2) Test
- Stephen B. Kaye
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?